0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmune Disorder Drug Delivery Devices Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-2M8494
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autoimmune Disorder Drug Delivery Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Autoimmune Disorder Drug Delivery Devices Market Research Report 2023

Code: QYRE-Auto-2M8494
Report
February 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Autoimmune Disorder Drug Delivery Devices Market

The global Autoimmune Disorder Drug Delivery Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Autoimmune Disorder Drug Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Autoimmune Disorder Drug Delivery Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Autoimmune Disorder Drug Delivery Devices include BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter and West Pharma, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Devices.
The Autoimmune Disorder Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Autoimmune Disorder Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disorder Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • BD
  • Gerresheimer
  • Schott
  • J.O.Pharma
  • Nipro
  • Roselabs
  • Fresenius Kabi
  • Baxter
  • West Pharma
  • Terumo
  • Taisei Kako
  • MedXL
  • Cardinal Health
  • Guerbet
  • Catalent
  • Weigao
  • Stevanato
  • Rovi CM
  • Zibo Minkang
  • Vetter Pharma

Segment by Type

  • Pen Injectors
  • Auto-Injectors
  • Pre-filled Syringes
  • Vials

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Autoimmune Disorder Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Autoimmune Disorder Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Autoimmune Disorder Drug Delivery Devices Market Report

Report MetricDetails
Report NameGlobal Autoimmune Disorder Drug Delivery Devices Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Autoimmune Disorder Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Autoimmune Disorder Drug Delivery Devices
1.2 Autoimmune Disorder Drug Delivery Devices Segment by Type
1.2.1 Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2023-2029)
1.2.2 Pen Injectors
1.2.3 Auto-Injectors
1.2.4 Pre-filled Syringes
1.2.5 Vials
1.3 Autoimmune Disorder Drug Delivery Devices Segment by Application
1.3.1 Global Autoimmune Disorder Drug Delivery Devices Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Autoimmune Disorder Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Disorder Drug Delivery Devices Revenue 2018-2029
1.4.2 Global Autoimmune Disorder Drug Delivery Devices Sales 2018-2029
1.4.3 Global Autoimmune Disorder Drug Delivery Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Autoimmune Disorder Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Autoimmune Disorder Drug Delivery Devices Average Price by Manufacturers (2018-2023)
2.4 Global Autoimmune Disorder Drug Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Product Type & Application
2.7 Autoimmune Disorder Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Autoimmune Disorder Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autoimmune Disorder Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Autoimmune Disorder Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autoimmune Disorder Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Autoimmune Disorder Drug Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Autoimmune Disorder Drug Delivery Devices Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2018-2029
3.2.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2018-2023
3.2.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Region: 2024-2029
3.3 Global Autoimmune Disorder Drug Delivery Devices Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2018-2029
3.3.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2018-2023
3.3.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2024-2029
3.4 North America Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2029)
3.4.3 North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2029)
3.5.3 Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2029)
3.7.3 Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2029)
4.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2018-2023)
4.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2024-2029)
4.1.3 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2018-2029)
4.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2018-2023)
4.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2024-2029)
4.2.3 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Autoimmune Disorder Drug Delivery Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2029)
5.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2018-2023)
5.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2024-2029)
5.1.3 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2018-2029)
5.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2018-2023)
5.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Application (2024-2029)
5.2.3 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Autoimmune Disorder Drug Delivery Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BD Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Gerresheimer
6.2.1 Gerresheimer Corporation Information
6.2.2 Gerresheimer Description and Business Overview
6.2.3 Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.2.5 Gerresheimer Recent Developments/Updates
6.3 Schott
6.3.1 Schott Corporation Information
6.3.2 Schott Description and Business Overview
6.3.3 Schott Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Schott Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.3.5 Schott Recent Developments/Updates
6.4 J.O.Pharma
6.4.1 J.O.Pharma Corporation Information
6.4.2 J.O.Pharma Description and Business Overview
6.4.3 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.4.5 J.O.Pharma Recent Developments/Updates
6.5 Nipro
6.5.1 Nipro Corporation Information
6.5.2 Nipro Description and Business Overview
6.5.3 Nipro Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nipro Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.5.5 Nipro Recent Developments/Updates
6.6 Roselabs
6.6.1 Roselabs Corporation Information
6.6.2 Roselabs Description and Business Overview
6.6.3 Roselabs Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Roselabs Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.6.5 Roselabs Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Baxter
6.8.1 Baxter Corporation Information
6.8.2 Baxter Description and Business Overview
6.8.3 Baxter Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Baxter Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.8.5 Baxter Recent Developments/Updates
6.9 West Pharma
6.9.1 West Pharma Corporation Information
6.9.2 West Pharma Description and Business Overview
6.9.3 West Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 West Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.9.5 West Pharma Recent Developments/Updates
6.10 Terumo
6.10.1 Terumo Corporation Information
6.10.2 Terumo Description and Business Overview
6.10.3 Terumo Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Terumo Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.10.5 Terumo Recent Developments/Updates
6.11 Taisei Kako
6.11.1 Taisei Kako Corporation Information
6.11.2 Taisei Kako Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.11.3 Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.11.5 Taisei Kako Recent Developments/Updates
6.12 MedXL
6.12.1 MedXL Corporation Information
6.12.2 MedXL Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.12.3 MedXL Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.12.4 MedXL Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.12.5 MedXL Recent Developments/Updates
6.13 Cardinal Health
6.13.1 Cardinal Health Corporation Information
6.13.2 Cardinal Health Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.13.3 Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.13.5 Cardinal Health Recent Developments/Updates
6.14 Guerbet
6.14.1 Guerbet Corporation Information
6.14.2 Guerbet Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.14.3 Guerbet Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Guerbet Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.14.5 Guerbet Recent Developments/Updates
6.15 Catalent
6.15.1 Catalent Corporation Information
6.15.2 Catalent Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.15.3 Catalent Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Catalent Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.15.5 Catalent Recent Developments/Updates
6.16 Weigao
6.16.1 Weigao Corporation Information
6.16.2 Weigao Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.16.3 Weigao Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Weigao Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.16.5 Weigao Recent Developments/Updates
6.17 Stevanato
6.17.1 Stevanato Corporation Information
6.17.2 Stevanato Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.17.3 Stevanato Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Stevanato Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.17.5 Stevanato Recent Developments/Updates
6.18 Rovi CM
6.18.1 Rovi CM Corporation Information
6.18.2 Rovi CM Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.18.3 Rovi CM Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Rovi CM Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.18.5 Rovi CM Recent Developments/Updates
6.19 Zibo Minkang
6.19.1 Zibo Minkang Corporation Information
6.19.2 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.19.3 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.19.5 Zibo Minkang Recent Developments/Updates
6.20 Vetter Pharma
6.20.1 Vetter Pharma Corporation Information
6.20.2 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Description and Business Overview
6.20.3 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Portfolio
6.20.5 Vetter Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmune Disorder Drug Delivery Devices Industry Chain Analysis
7.2 Autoimmune Disorder Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmune Disorder Drug Delivery Devices Production Mode & Process
7.4 Autoimmune Disorder Drug Delivery Devices Sales and Marketing
7.4.1 Autoimmune Disorder Drug Delivery Devices Sales Channels
7.4.2 Autoimmune Disorder Drug Delivery Devices Distributors
7.5 Autoimmune Disorder Drug Delivery Devices Customers
8 Autoimmune Disorder Drug Delivery Devices Market Dynamics
8.1 Autoimmune Disorder Drug Delivery Devices Industry Trends
8.2 Autoimmune Disorder Drug Delivery Devices Market Drivers
8.3 Autoimmune Disorder Drug Delivery Devices Market Challenges
8.4 Autoimmune Disorder Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Autoimmune Disorder Drug Delivery Devices Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Autoimmune Disorder Drug Delivery Devices Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Autoimmune Disorder Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Autoimmune Disorder Drug Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Product Type & Application
    Table 12. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Devices, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Autoimmune Disorder Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Devices as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Autoimmune Disorder Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Autoimmune Disorder Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
    Table 18. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2018-2023)
    Table 19. Global Autoimmune Disorder Drug Delivery Devices Sales by Region (2024-2029) & (K Units)
    Table 20. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2024-2029)
    Table 21. Global Autoimmune Disorder Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2018-2023)
    Table 23. Global Autoimmune Disorder Drug Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2024-2029)
    Table 25. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
    Table 27. North America Autoimmune Disorder Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
    Table 28. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Autoimmune Disorder Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Autoimmune Disorder Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Type (2018-2023)
    Table 51. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Type (2024-2029)
    Table 52. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2018-2023)
    Table 53. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2024-2029)
    Table 54. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2018-2023)
    Table 57. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2024-2029)
    Table 58. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Application (2018-2023)
    Table 61. Global Autoimmune Disorder Drug Delivery Devices Sales (K Units) by Application (2024-2029)
    Table 62. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2018-2023)
    Table 63. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2024-2029)
    Table 64. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Autoimmune Disorder Drug Delivery Devices Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2018-2023)
    Table 67. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2024-2029)
    Table 68. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2024-2029)
    Table 70. BD Corporation Information
    Table 71. BD Description and Business Overview
    Table 72. BD Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. BD Autoimmune Disorder Drug Delivery Devices Product
    Table 74. BD Recent Developments/Updates
    Table 75. Gerresheimer Corporation Information
    Table 76. Gerresheimer Description and Business Overview
    Table 77. Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Gerresheimer Autoimmune Disorder Drug Delivery Devices Product
    Table 79. Gerresheimer Recent Developments/Updates
    Table 80. Schott Corporation Information
    Table 81. Schott Description and Business Overview
    Table 82. Schott Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Schott Autoimmune Disorder Drug Delivery Devices Product
    Table 84. Schott Recent Developments/Updates
    Table 85. J.O.Pharma Corporation Information
    Table 86. J.O.Pharma Description and Business Overview
    Table 87. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product
    Table 89. J.O.Pharma Recent Developments/Updates
    Table 90. Nipro Corporation Information
    Table 91. Nipro Description and Business Overview
    Table 92. Nipro Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Nipro Autoimmune Disorder Drug Delivery Devices Product
    Table 94. Nipro Recent Developments/Updates
    Table 95. Roselabs Corporation Information
    Table 96. Roselabs Description and Business Overview
    Table 97. Roselabs Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Roselabs Autoimmune Disorder Drug Delivery Devices Product
    Table 99. Roselabs Recent Developments/Updates
    Table 100. Fresenius Kabi Corporation Information
    Table 101. Fresenius Kabi Description and Business Overview
    Table 102. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product
    Table 104. Fresenius Kabi Recent Developments/Updates
    Table 105. Baxter Corporation Information
    Table 106. Baxter Description and Business Overview
    Table 107. Baxter Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Baxter Autoimmune Disorder Drug Delivery Devices Product
    Table 109. Baxter Recent Developments/Updates
    Table 110. West Pharma Corporation Information
    Table 111. West Pharma Description and Business Overview
    Table 112. West Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. West Pharma Autoimmune Disorder Drug Delivery Devices Product
    Table 114. West Pharma Recent Developments/Updates
    Table 115. Terumo Corporation Information
    Table 116. Terumo Description and Business Overview
    Table 117. Terumo Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Terumo Autoimmune Disorder Drug Delivery Devices Product
    Table 119. Terumo Recent Developments/Updates
    Table 120. Taisei Kako Corporation Information
    Table 121. Taisei Kako Description and Business Overview
    Table 122. Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Taisei Kako Autoimmune Disorder Drug Delivery Devices Product
    Table 124. Taisei Kako Recent Developments/Updates
    Table 125. MedXL Corporation Information
    Table 126. MedXL Description and Business Overview
    Table 127. MedXL Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. MedXL Autoimmune Disorder Drug Delivery Devices Product
    Table 129. MedXL Recent Developments/Updates
    Table 130. Cardinal Health Corporation Information
    Table 131. Cardinal Health Description and Business Overview
    Table 132. Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Cardinal Health Autoimmune Disorder Drug Delivery Devices Product
    Table 134. Cardinal Health Recent Developments/Updates
    Table 135. Guerbet Corporation Information
    Table 136. Guerbet Description and Business Overview
    Table 137. Guerbet Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 138. Guerbet Autoimmune Disorder Drug Delivery Devices Product
    Table 139. Guerbet Recent Developments/Updates
    Table 140. Catalent Corporation Information
    Table 141. Catalent Description and Business Overview
    Table 142. Catalent Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 143. Catalent Autoimmune Disorder Drug Delivery Devices Product
    Table 144. Catalent Recent Developments/Updates
    Table 145. Weigao Corporation Information
    Table 146. Weigao Description and Business Overview
    Table 147. Weigao Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 148. Weigao Autoimmune Disorder Drug Delivery Devices Product
    Table 149. Weigao Recent Developments/Updates
    Table 150. Stevanato Corporation Information
    Table 151. Stevanato Description and Business Overview
    Table 152. Stevanato Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 153. Stevanato Autoimmune Disorder Drug Delivery Devices Product
    Table 154. Stevanato Recent Developments/Updates
    Table 155. Rovi CM Corporation Information
    Table 156. Rovi CM Description and Business Overview
    Table 157. Rovi CM Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 158. Rovi CM Autoimmune Disorder Drug Delivery Devices Product
    Table 159. Rovi CM Recent Developments/Updates
    Table 160. Zibo Minkang Corporation Information
    Table 161. Zibo Minkang Description and Business Overview
    Table 162. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 163. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product
    Table 164. Zibo Minkang Recent Developments/Updates
    Table 165. Vetter Pharma Corporation Information
    Table 166. Vetter Pharma Description and Business Overview
    Table 167. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 168. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product
    Table 169. Vetter Pharma Recent Developments/Updates
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Autoimmune Disorder Drug Delivery Devices Distributors List
    Table 173. Autoimmune Disorder Drug Delivery Devices Customers List
    Table 174. Autoimmune Disorder Drug Delivery Devices Market Trends
    Table 175. Autoimmune Disorder Drug Delivery Devices Market Drivers
    Table 176. Autoimmune Disorder Drug Delivery Devices Market Challenges
    Table 177. Autoimmune Disorder Drug Delivery Devices Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Autoimmune Disorder Drug Delivery Devices
    Figure 2. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Autoimmune Disorder Drug Delivery Devices Market Share by Type in 2022 & 2029
    Figure 4. Pen Injectors Product Picture
    Figure 5. Auto-Injectors Product Picture
    Figure 6. Pre-filled Syringes Product Picture
    Figure 7. Vials Product Picture
    Figure 8. Global Autoimmune Disorder Drug Delivery Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Autoimmune Disorder Drug Delivery Devices Market Share by Application in 2022 & 2029
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Global Autoimmune Disorder Drug Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Autoimmune Disorder Drug Delivery Devices Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Autoimmune Disorder Drug Delivery Devices Sales (2018-2029) & (K Units)
    Figure 15. Global Autoimmune Disorder Drug Delivery Devices Average Price (US$/Unit) & (2018-2029)
    Figure 16. Autoimmune Disorder Drug Delivery Devices Report Years Considered
    Figure 17. Autoimmune Disorder Drug Delivery Devices Sales Share by Manufacturers in 2022
    Figure 18. Global Autoimmune Disorder Drug Delivery Devices Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Devices Players: Market Share by Revenue in 2022
    Figure 20. Autoimmune Disorder Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Autoimmune Disorder Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2029)
    Figure 23. North America Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2029)
    Figure 24. United States Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2029)
    Figure 27. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2018-2029)
    Figure 35. China Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. China Taiwan Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Autoimmune Disorder Drug Delivery Devices by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Devices by Type (2018-2029)
    Figure 56. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Autoimmune Disorder Drug Delivery Devices by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Devices by Application (2018-2029)
    Figure 59. Global Autoimmune Disorder Drug Delivery Devices Price (US$/Unit) by Application (2018-2029)
    Figure 60. Autoimmune Disorder Drug Delivery Devices Value Chain
    Figure 61. Autoimmune Disorder Drug Delivery Devices Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS